Allurion Technologies (ALUR) Other Accumulated Expenses (2022 - 2026)
Allurion Technologies (ALUR) posted Other Accumulated Expenses of $2.4 million for Q1 2026, down 25.62% on a QoQ basis from $3.2 million in Q4 2025, and down 41.97% year-over-year from $4.1 million in Q1 2025.
Allurion Technologies (ALUR) Other Accumulated Expenses (2022 - 2026) Analysis & Trends
Allurion Technologies' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $2.4 million for Q1 2026.
- Quarterly Other Accumulated Expenses fell 41.97% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (down 41.97% YoY) and the FY2025 annual result came in at $3.2 million, down 38.13% from the prior year.
- Other Accumulated Expenses was $2.4 million for Q1 2026 at Allurion Technologies, down from $3.2 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $5.1 million in Q4 2024 and bottomed at $2.4 million in Q1 2026.
- A 5-year average of $3.6 million and a median of $3.5 million in 2025 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Other Accumulated Expenses surged 50.17% — and 2026, when it tumbled 41.97%.
- Allurion Technologies' Other Accumulated Expenses stood at $2.6 million in 2022, then jumped by 50.17% to $4.0 million in 2023, then increased by 29.48% to $5.1 million in 2024, then slumped by 38.13% to $3.2 million in 2025, then decreased by 25.62% to $2.4 million in 2026.
- Business Quant data shows ALUR's Other Accumulated Expenses at $2.4 million in Q1 2026, $3.2 million in Q4 2025, and $3.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.36 Mn |
| Dec 31, 2025 | 3.18 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Jun 30, 2025 | 3.94 Mn |
| Mar 31, 2025 | 4.07 Mn |
| Dec 31, 2024 | 5.14 Mn |
| Sep 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | 4.36 Mn |
| Mar 31, 2024 | 3.15 Mn |
| Dec 31, 2023 | 3.97 Mn |
| Sep 30, 2023 | 3.15 Mn |
| Jun 30, 2023 | 3.32 Mn |
| Dec 31, 2022 | 2.64 Mn |